AVR charting, page-57

Was looking more for company published timelines, its been a little quiet on that front.

Worst case scenario AVROs dont hit and another CR comes our way early next year, but I think for that to have any legs they would need to give some kind of update eg: talks/ meeting dates/ feedback from FDA, large pharma partner or angel investor (who wont flip the inevitable freebies they will get) to avoid a decline back to sub $5.

.... on a more optimistic note we could an announcement out of the FDA which triggers a pharma stampede and we all walk away with bags of cash.